22 Jul C3i Center
Jamie Sharp, Ph.D., Associate Director of Programs
Oct. 8 | 5:45pm | FLW Ballroom G
Montreal, Canada
(Private)
C3i Center Inc is a leading CDMO in Canada offering in-house turnkey services for CGTs from process development to commercialization. C3i is the only CDMO in Canada with a Drug Establishment Licesnse (DEL) for the manufacture of a commercial cell therapy. C3i expects to receive EMA approval for the commercial manufacture cell therapy for its facility in Canada for EU market which will make it one of a few CDMOs in NA with such approval. C3i has developed phase appropriate QC testing and CAP-accredited labs offering immune monitoring, diagnostics and biomarker development, clinical CRO servicesas well as investing in innovative CGT therapy companies. C3i personnel have been manufacturing cell therapies for over 15 years strong process development experience in diverse cell types including: CAR-Ts, Treg, TCRs, MSCs, DC, IPSCs, allogeneic, viral and non-viral transduction and CRISPR-editing. C3i is partner-focused, patient-driven whereby failure is not an option. C3i has a high manufacturing success rate of 99% as we understand that patient’s time is measured in days with no room for error. C3i works hard to integrate cost-efficiency, we offer very attractive COGS.
